The Brussels International Declaration on Lipoprotein(a) Testing and Management

Simple item page
dc.creatorKronenberg, Florian
dc.creatorBedlington, Nicola
dc.creatorAdemi, Zanfina
dc.creatorGeantå, Marius
dc.creatorSilberzahn, Tobias
dc.creatorRijken, Marc
dc.creatorKaal, Aedan
dc.creatorHarada-Shiba, Mariko
dc.creatorChen, Zhenyue
dc.creatorThanassoulis, George
dc.creatorEliasen, Bogi
dc.creatorEiselé, Jean-Luc
dc.creatorWiegman, Albert
dc.creatorBallantyne, Christie M.
dc.creatorBroome, Emma
dc.creatorCalabrò, Michele
dc.creatorCorral, Pablo
dc.creatorDol, Annelies
dc.creatorDonato, Leslie J.
dc.creatorEvans, Elsie
dc.creatorFunabashi, Sayaka
dc.creatorGouni-Berthold, Ioanna
dc.creatorGutiérrez Ibarluzea, Iñaki
dc.creatorJohnson, Neil
dc.creatorLane, Joanna
dc.creatorMora, Samia
dc.creatorNordestgaard, Børge G.
dc.creatorPećin, Ivan
dc.creatorKaal-Poppelaars, Renate
dc.creatorLanglois, Michel R.
dc.creatorRay, Kausik K.
dc.creatorRodenbach, Arthur
dc.creatorSantos, Raul D.
dc.creatorStroes, Erik S.G.
dc.creatorTada, Hayato
dc.creatorVrablík, Michal
dc.creatorWinokur, Michelle
dc.creatorYoshida, Masayuki
dc.creatorNicholls, Stephen J.
dc.creatorDaccord, Magdalena
dc.date2025
dc.date.accessioned2026-03-20T22:18:45Z
dc.date.available2026-03-20T22:18:45Z
dc.descriptionThere is striking evidence that a high lipoprotein(a) [Lp(a)] concentration is a strong, independent, and causal cardiovascular risk factor. However, Lp(a) testing rates are very low (1 %–2 %) despite the fact that 1 in 5 individuals have elevated Lp(a) concentrations. The Brussels International Declaration on Lp(a) Testing and Management was co-created by the Lp(a) International Task Force and global leaders at the Lp(a) Global Summit, held in Brussels, Belgium, on March 24–25, 2025. The event, organized by FH Europe Foundation, brought together scientific experts, people with the lived experience of elevated Lp(a) and policy makers from the European Institutions and World Health Organization. The World Heart Federation, Global Heart Hub, and European Alliance for Cardiovascular Health and scientific organizations such as European Atherosclerosis Society, and International Atherosclerosis Society were formal partners. The Summit was hosted by a Member of the European Parliament, Romana Jerkovi ́c, and held under the patronage of the Polish presidency of the Council of the European Union. The Declaration calls for 1) integration of Lp(a) testing and management into Global, European and National Cardiovascular Health Plans; 2) appropriate investment, policy and programmes in targeting Lp(a) testing and management based on a recent study demonstrating the substantial overall cost-saving to health systems acros the globe; 3) political commitment to mandate systematic Lp(a) testing at least once during a person’s lifetime, ideally at an early age, with full reimbursement; 4) incorporation of Lp(a) test results in the context of a person’s cardiovascular risk assessment, with development of personalised cardiovascular health roadmaps as needed, without fear of dredit aiscrimination; 5) investment in public and healthcare professional education to increase awareness of Lp(a) and its impact on cardiovascular health.
dc.descriptionFil: Kronenberg, Florian. Institute of Genetic Epidemiology, Medical University of Innsbruck; Austria.
dc.descriptionFil: Kronenberg, Florian. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Bedlington, Nicola. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Ademi, Zanfina. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Ademi, Zanfina. Health Economics and Policy Evaluation Research (HEPER) Group, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University; Australia.
dc.descriptionFil: Geantå, Marius. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Geantå, Marius. Center for Innovation in Medicine; Romania.
dc.descriptionFil: Silberzahn, Tobias. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Rijken, Marc. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Kaal, Aedan. FH Europe Foundation; Países Bajos..
dc.descriptionFil: Harada-Shiba, Mariko. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Harada-Shiba, Mariko. Cardiovascular Center, Osaka Medical and Pharmaceutical University; Japón.
dc.descriptionFil: Chen, Zhenyue. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Chen, Zhenyue. Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine; China.
dc.descriptionFil: Thanassoulis, George. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Thanassoulis, George. Preventive and Genomic Cardiology, McGill University Health Center; Canadá.
dc.descriptionFil: Eliasen, Bogi. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Eliasen, Bogi. Movement Health Foundation; Suiza.
dc.descriptionFil: Eiselé, Jean-Luc. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Eiselé, Jean-Luc. World Heart Federation (WHF); Suiza.
dc.descriptionFil: Weigman, Albert. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Weigman, Albert. Department of Pediatrics Amsterdam University Medical Centers, University of Amsterdam; Países Bajos.
dc.descriptionFil: Ballantyne, Christie M. Sections of Cardiology and Cardiovascular Research, Department of Medicine, Baylor College of Medicine and the Texas Heart Institute; Estados Unidos.
dc.descriptionFil: Broome, Emma. FH Europe Foundation; Países Bajos.
dc.descriptionFil: Calabrò, Michele. European Regional and Local Health Authorities; Bélgica.
dc.descriptionFil: Corral, Pablo. Universidad FASTA. Facultad de Ciencias Médicas; Argentina.
dc.descriptionFil: Dol, Annalies. FH Europe Foundation; Países Bajos.
dc.descriptionFil: Donato, Leslie J. Department of Laboratory Medicine and Pathology, Mayo Clinic; Estados Unidos.
dc.descriptionFil: Evans, Elsie. FH Europe Foundation; Países Bajos.
dc.descriptionFil: Funabashi, Sayaka. Department of Cardiovascular Medicine, Kyorin University, Faculty of Medicine; Japón.
dc.descriptionFil: Gouni-Berthold, Ioanna. Center for Endocrinology, Diabetes and Preventive Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne; Alemania.
dc.descriptionFil: Gutierrez Ibarluzea, Iñaki. Stichting Health Clusternet; Países Bajos.
dc.descriptionFil: Johnson, Neil. Global Heart Hub; Irlanda.
dc.descriptionFil: Lane, Joanna. FH Europe Foundation; Países Bajos.
dc.descriptionFil: Lane, Joanna. Stichting Health Clusternet; Países Bajos.
dc.descriptionFil: Lane, Joanna. Centre for Health and Technology, University of South-Eastern Norway; Noruega.
dc.descriptionFil: Mora, Samia. International Atherosclerosis Society; Estados Unidos.
dc.descriptionFil: Mora, Samia. Center for Lipid Metabolomics, Brigham and Women’s Hospital, Harvard Medical School; Estados Unidos.
dc.descriptionFil: Nordestgaard, Børge G. Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte; Dinamarca.
dc.descriptionFil: Nordestgaard, Børge G. The Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte; Dinamarca.
dc.descriptionFil: Nordestgaard, Børge G. Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen; Dinamarca.
dc.descriptionFil: Pécin, Ivan. Zagreb School of Medicine, University of Zagreb, University Hospital Center Zagreb; Croacia.
dc.descriptionFil: Kaal-Poppelaars, Renate. FH Europe Foundation; Países Bajos.
dc.descriptionFil: Langlois, Michel R. EFLM (European Federation of Clinical Chemistry and Laboratory Medicine); Bélgica.
dc.descriptionFil: Ray, Kausik K. Department of Public Health and Primary Care, Imperial College London; Reino Unido.
dc.descriptionFil: Rodenbach, Arthur. Department of Internal Medicine and Pediatrics, Ghent University Hospital; Bélgica.
dc.descriptionFil: Santos, Raul D. Hospital Israelita Albert Einstein and University of Sao Paulo, Brasil.
dc.descriptionFil: Stroes, Erik S. G. Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, University of Amsterdam; Países Bajos.
dc.descriptionFil: Tada, Hayato. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University; Japón.
dc.descriptionFil: Vrablík, Michal. 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, General University Hospital; Republica Checa.
dc.descriptionFil: Winokur, Michelle. International Atherosclerosis Society; Estados Unidos.
dc.descriptionFil: Yoshida, Masayuki. Institute of Science Tokyo, Department of Medical Genetics; Japón.
dc.descriptionFil: Nicholls, Stephen J. Monash University Victoria Heart Institute; Australia.
dc.descriptionFil: Daccord, Magdalena. Lp(a) International Task Force, FH Europe Foundation; Países Bajos.
dc.descriptionFil: Daccord, Magdalena. FH Europe Foundation; Países Bajos.
dc.formatapplication/pdf
dc.identifier.citationKronenberg, F., Bedlington, N., Ademi, Z., Geantă, M., Silberzahn, T., Rijken, M., Kaal, A., Harada-Shiba, M., Chen, Z., Thanassoulis, G., Eliasen, B., Eiselé, J. L., Wiegman, A., Ballantyne, C. M., Broome, E., Calabrò, M., Corral, P., Dol, A., Donato, L. J., Evans, E., … Daccord, M. (2025). The Brussels International Declaration on Lipoprotein(a) Testing and Management. Atherosclerosis, 406, 119218. https://doi.org/10.1016/j.atherosclerosis.2025.119218
dc.identifier.issn0021-9150
dc.identifier.urihttps://dspace.ufasta.edu.ar/handle/123456789/87956
dc.languageeng
dc.publisherAtherosclerosis
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licences/by-nc-nd/3.0/deed.es_AR
dc.sourceThe Brussels International Declaration on Lipoprotein(a) Testing and Management. Atherosclerosis, 406, 119218.
dc.subjectLipoproteína (a)
dc.subjectRiesgo cardiovascular
dc.subjectDetección
dc.subjectEvaluación del riesgo cardiovascular
dc.subjectInvolucración del paciente
dc.titleThe Brussels International Declaration on Lipoprotein(a) Testing and Management
dc.typeinfo:eu-repo/semanticspte/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/accedVersion

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Corral_2025_0021-9150.pdf
Size:
6.57 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Libros, artículos de libros, artículos científicos en Ciencias Médicas